Transcriptomic changes in invasive residual cancer after neoadjuvant chemotherapy in patients with triple-negative breast cancer

被引：0
|
作者：
Orozco, Javier [1 ]
Manughian-Peter, Ayla [1 ]
Gago, Francisco [2 ]
Chang, Grace [1 ]
Grumley, Janie [1 ]
Marzese, Diego [1 ]
机构：
[1] Providence St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA USA
[2] Italian Hosp Mendoza, Mendoza, Argentina
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
581545
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [41] A brief review of treatment options for neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Tiwari, Akash
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (02) : 247 - 249
  • [42] Response to Neoadjuvant Chemotherapy and Survival in Japanese Patients with Triple-Negative Breast Cancer.
    Ohtani, S.
    Kochi, M.
    Ito, M.
    Takada, S.
    Matsuura, H.
    Higaki, K.
    CANCER RESEARCH, 2011, 71
  • [43] Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis
    Tian, Muyou
    Zhong, Yahua
    Zhou, Fuxiang
    Xie, Conghua
    Zhou, Yunfeng
    Liao, Zhengkai
    ONCOLOGY LETTERS, 2015, 9 (06) : 2825 - 2832
  • [44] Response and prognosis of taxanes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer
    Jiannan Wu
    Shunrong Li
    Weijuan Jia
    Fengxi Su
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1505 - 1510
  • [45] Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations
    Katherine Clifton
    Angelica Gutierrez-Barrera
    Junsheng Ma
    Roland Bassett
    Jennifer Litton
    Henry Kuerer
    Stacy Moulder
    Constance Albarracin
    Gabriel Hortobagyi
    Banu Arun
    Breast Cancer Research and Treatment, 2018, 170 : 101 - 109
  • [46] Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations
    Clifton, Katherine
    Gutierrez-Barrera, Angelica
    Ma, Junsheng
    Bassett, Roland, Jr.
    Litton, Jennifer
    Kuerer, Henry
    Moulder, Stacy
    Albarracin, Constance
    Hortobagyi, Gabriel
    Arun, Banu
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 170 (01) : 101 - 109
  • [47] Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy
    Masuda, Hiroko
    Harano, Kenichi
    Miura, Sakiko
    Wang, Ying
    Hirota, Yuko
    Harada, Oi
    Jolly, Mohit Kumar
    Matsunaga, Yuki
    Lim, Bora
    Wood, Anita L.
    Parinyanitikul, Napa
    Lee, Hee Jin
    Gong, Gyungyub
    George, Jason T.
    Levine, Herbert
    Lee, Jangsoon
    Wang, Xiaoping
    Lucci, Anthony
    Rao, Arvind
    Schweitzer, Brock L.
    Lawrence, O. Rayne
    Seitz, Robert S.
    Morris, Stephan W.
    Hout, David R.
    Nakamura, Seigo
    Krishnamurthy, Savitri
    Ueno, Naoto T.
    JCO PRECISION ONCOLOGY, 2022, 6
  • [48] Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients
    Hiroko Masuda
    Norikazu Masuda
    Yoshinori Kodama
    Masami Ogawa
    Michiko Karita
    Jun Yamamura
    Kazunori Tsukuda
    Hiroyoshi Doihara
    Shinichiro Miyoshi
    Masayuki Mano
    Shoji Nakamori
    Toshimasa Tsujinaka
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 911 - 917
  • [49] BRCAness and prognosis of triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
    Akashi-Tanaka, Sadako
    Tanino, Yuichi
    Yamamoto, Yutaka
    Nishimiya, Hiroshi
    Yamamoto-ibusuki, Mutsuko
    Iwase, Hirotaka
    Nakamura, Seigo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    da Silva, Jesse Lopes
    de Albuquerque, Lucas Zanetti
    Rodrigues, Fabiana Resende
    de Mesquita, Guilherme Gomes
    Fernandes, Priscila Valverde
    Thuler, Luiz Claudio Santos
    de Melo, Andreia Cristina
    FRONTIERS IN ONCOLOGY, 2021, 11
12345